Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

Primary Treatment of Light Chain Amyloidosis with Bortezomib, Lenalidomide, and Dexamethasone (VRD): Effective Regimen Inducing Response w/in 3 mths, Toxicity Manageable

19 views
November 18, 2019
0 Comments
Login to view comments. Click here to Login